title: Molecular profiling of angiogenesis markers.
abstract: The goal of this study was to develop a sensitive, simple, and widely applicable assay to measure copy numbers of specific mRNAs using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), and identify a profile of gene expression closely associated with angiogenesis. We measured a panel of nine potential angiogenesis markers from a mouse transgenic model of prostate adenocarcinoma (TRAMP) and a mouse skin model of vascular endothelial growth factor (VEGF)-driven angiogenesis. In both models, expression of VEGF correlated with expression of mRNAs encoding other angiogenic cytokines (angiopoietin-1 and angiopoietin-2), endothelial cell receptor tyrosine kinases (Flt-1, KDR, Tie-1), and endothelial cell adhesion molecules (VE-cadherin, PECAM-1). Relative to control, in dermis highly stimulated by VEGF, the Ang-2 mRNA transcript numbers increased 35-fold, PECAM-1 and VE-cadherin increased 10-fold, Tie-1 increased 8-fold, KDR and Flt-1 each increased 4-fold, and Ang-1 increased 2-fold. All transcript numbers were correspondingly reduced in skin with less VEGF expression, indicating a relationship of each of these seven markers with VEGF. Thus, this study identifies a highly efficient method for precise quantification of a panel of seven specific mRNAs that correlate with VEGF expression and VEGF-induced neovascularization, and it provides evidence that real-time quantitative RT-PCR offers a highly sensitive strategy for monitoring angiogenesis.
authors.affiliation: Department of Ophthalmology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Shu-Ching
authors.initials: SC
authors.lastname: Shih
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Robinson
authors.forename: Carole A
authors.initials: CA
authors.lastname: Perruzzi
authors.forename: Alfonso
authors.initials: A
authors.lastname: Calvo
authors.forename: Kartiki
authors.initials: K
authors.lastname: Desai
authors.forename: Jeffery E
authors.initials: JE
authors.lastname: Green
authors.forename: Iqbal U
authors.initials: IU
authors.lastname: Ali
authors.forename: Lois E H
authors.initials: LE
authors.lastname: Smith
authors.forename: Donald R
authors.initials: DR
authors.lastname: Senger
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics; D000818:Animals; D015415:Biomarkers; D016228:Endothelial Growth Factors / Q000494:pharmacology; D018628:Gene Dosage; D020869:Gene Expression Profiling; D008222:Lymphokines / Q000494:pharmacology; D008297:Male; D051379:Mice; D009389:Neovascularization, Pathologic / Q000235:genetics*; D018919:Neovascularization, Physiologic / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D012867:Skin / Q000098:blood supply / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D015415:Biomarkers; D016228:Endothelial Growth Factors; D008222:Lymphokines; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors